pci-32765 and Substance-Withdrawal-Syndrome

pci-32765 has been researched along with Substance-Withdrawal-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for pci-32765 and Substance-Withdrawal-Syndrome

ArticleYear
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.
    British journal of haematology, 2018, Volume: 182, Issue:5

    Topics: Adenine; Adult; Agammaglobulinaemia Tyrosine Kinase; Aged; Benzamides; Disease Progression; Drug Resistance; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Mutation; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazines; Pyrazoles; Pyrimidines; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome

2018
Ibrutinib withdrawal symptoms in patients with Waldenström macroglobulinemia.
    Haematologica, 2018, Volume: 103, Issue:7

    Topics: Adenine; Antineoplastic Agents; Biomarkers; Humans; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Substance Withdrawal Syndrome; Waldenstrom Macroglobulinemia; Withholding Treatment

2018